Mari Kogo

Hatanodai, 1428555, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 47 publications

Sepsis-Specific Risk Factors for Augmented Renal Clearance (ARC) and the Effect of Inflammation on Duration of ARC in Patients with Sepsis: A Single-Center Retrospective Cohort Study.

Sepsis-Specific Risk Factors for Augmented Renal Clearance (ARC) and the Effect of Inflammation on Duration of ARC in Patients with Sepsis: A Single-Center Retrospective Cohort Study.

Journal: Journal of clinical medicine

Published: June 15, 2026

Factors Associated With Loop Diuretic De-escalation in Patients With Acute Decompensated Heart Failure: The Influence of Guideline Directed Medical Therapy Initiation.

Factors Associated With Loop Diuretic De-escalation in Patients With Acute Decompensated Heart Failure: The Influence of Guideline Directed Medical Therapy Initiation.

Journal: Journal of cardiovascular pharmacology and therapeutics

Published: March 05, 2026

Impact of Neoadjuvant Docetaxel, Cisplatin, and 5-Fluorouracil-Induced Neutropenia on Histological Tumor Response in Esophageal Squamous Cell Carcinoma: A Retrospective Study.

Impact of Neoadjuvant Docetaxel, Cisplatin, and 5-Fluorouracil-Induced Neutropenia on Histological Tumor Response in Esophageal Squamous Cell Carcinoma: A Retrospective Study.

Journal: Oncology

Published: February 21, 2026

Impact of Chemotherapy and Anticancer Agent Type on 30-Day All-Cause In-Hospital Mortality of Venous Thromboembolism Patients With Cancer in Japan.

Impact of Chemotherapy and Anticancer Agent Type on 30-Day All-Cause In-Hospital Mortality of Venous Thromboembolism Patients With Cancer in Japan.

Journal: Circulation reports

Published: July 29, 2025

Development of an LC-MS/MS method for the quantification of sunitinib and its metabolites in human nail and skin.

Development of an LC-MS/MS method for the quantification of sunitinib and its metabolites in human nail and skin.

Journal: Journal of pharmaceutical and biomedical analysis

Published: June 26, 2025

Atypical Femoral Fracture During Long-Term Treatment With Denosumab in Patients With Metastatic Bone Tumors.

Atypical Femoral Fracture During Long-Term Treatment With Denosumab in Patients With Metastatic Bone Tumors.

Journal: Cureus

Published: May 28, 2025

Atypical Femoral Fracture in Patients With Metastatic Bone Tumors: An Analysis Based on the Japanese Adverse Drug Event Reaction Database (JADER).

Atypical Femoral Fracture in Patients With Metastatic Bone Tumors: An Analysis Based on the Japanese Adverse Drug Event Reaction Database (JADER).

Journal: Cureus

Published: May 02, 2025

Factors Associated with Initial Treatment Failure in Inpatients with Exacerbation of Chronic Obstructive Pulmonary Disease: A Cohort Study.

Factors Associated with Initial Treatment Failure in Inpatients with Exacerbation of Chronic Obstructive Pulmonary Disease: A Cohort Study.

Journal: International journal of chronic obstructive pulmonary disease

Published: January 10, 2025

Factors Associated With Sacubitril/Valsartan Continuation and the Methods of Combining Heart Failure Medications in Patients With Heart Failure.

Factors Associated With Sacubitril/Valsartan Continuation and the Methods of Combining Heart Failure Medications in Patients With Heart Failure.

Journal: The Annals of pharmacotherapy

Published: September 04, 2024

Variations in serum concentrations of sunitinib and its metabolites in patients receiving long-term sunitinib treatment.

Variations in serum concentrations of sunitinib and its metabolites in patients receiving long-term sunitinib treatment.

Journal: Cancer chemotherapy and pharmacology

Published: August 31, 2024

Relationship between the combination of platelet count and neutrophil-lymphocyte ratio and prognosis of patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitors plus chemotherapy: A retrospective cohort study.

Relationship between the combination of platelet count and neutrophil-lymphocyte ratio and prognosis of patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitors plus chemotherapy: A retrospective cohort study.

Journal: Thoracic cancer

Published: May 02, 2024

Cost-effectiveness analysis of first line pembrolizumab monotherapy for high programmed cell death ligand 1 expressed, advanced non-small cell lung cancer in Japan.

Cost-effectiveness analysis of first line pembrolizumab monotherapy for high programmed cell death ligand 1 expressed, advanced non-small cell lung cancer in Japan.

Journal: International journal of clinical pharmacy

Published: April 15, 2024

Showing 1-12 of 47

Last Updated: 09/26/2026